Tikcro Technologies Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TIKRF research report →
Price Chart
About the company
Tikcro Technologies Ltd. , an Israeli enterprise, is primarily involved in advancing biotechnology projects. Among its offerings is anti-cytotoxic T-lymphocyte-associated protein 4, which is utilized for immunotherapeutic approaches to cancer.
- CEO
- Aviv Boim
- IPO
- 2000
- HQ
- Hadera, IL
Get TickerSpark's AI analysis on TIKRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.09M
- P/E
- -2.27
- PEG
- -0.03
- P/S
- 0.00
- P/B
- 0.29
- EV/EBITDA
- 7.44
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -12.00%
- ROIC
- -13.69%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-513,000
- Net Income
- $-478,000+48.5%
- EPS
- $-0.05+48.5%
- OCF Growth
- +49.2%
- FCF Growth
- +49.3%
- 52W High
- $0.30
- 52W Low
- $0.05
- 50D MA
- $0.13
- 200D MA
- $0.15
- Beta
- -1.76
- RSI (14)
- 87
- Avg Volume
- 466
No earnings-call transcripts are available for TIKRF yet.
- Free Float
- 48.7%
- Shares Outstanding
- 9.87M
- Float Shares
- 4.81M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 18, 06 | BRONSON STEVEN N | buy | 36,506 |
| Aug 11, 06 | BRONSON STEVEN N | buy | 65,969 |
| Jul 14, 06 | BRONSON STEVEN N | buy | 65,655 |
| May 25, 06 | BRONSON STEVEN N | buy | 184,813 |
| Apr 25, 06 | BRONSON STEVEN N | buy | 86,257 |
| Apr 7, 06 | BRONSON STEVEN N | other | 0 |
| Apr 7, 06 | BRONSON STEVEN N | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TIKRF coverage
Recent articles, reports, and earnings notes.
No research on TIKRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TIKRF report →Tikcro Technologies Announces Extraordinary General Meeting
prnewswire.com · Mar 29
Tikcro Technologies to Proceed to Distribute Net Cash to Shareholders
prnewswire.com · Mar 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.